Affiliation:
1. School of Chemistry & Physics, University of KwaZulu-Natal, Westville Campus, Chilten Hills, Private Bag 54001, Durban-4000, south africa
2. Department of Chemistry, GITAM Institute of Sciences, GITAM University, Visakhapatnam, Andhra Pradesh, India
Abstract
Background:
Antioxidants are proficient of stabilizing agents in the target cells and biological
systems. The homeostatic equilibrium between the reactive oxygen species and endogenous
antioxidants is important in maintaining healthy tissues. As some antioxidant agent’s show improved
resistance, it is necessary to design the new heterocyclic molecules to form potent antioxidant
agents with promising pharmacological applications. Moreover, thienopyrimidine derivatives
has been the subject of much research due to their significance in different applications and their
extensive potential pharmacological and medicinal activities like antibacterial, antifungal, anticancer,
anticonvulsant, anti-inflammatory, analgesic, anti-viral, anti-oxidant, anti-diabetic and antimalarial
properties. Although, recently rhodanine was reported as privileged hybrid in drug discovery
and exhibited pharmacological activities such as anti-malarial, antibacterial, antiviral, antidiabetic
agents. Hence, the development of new molecules within the scope of synthetic procedure
of thienopyrimidine scaffold for heterocyclic synthesis would be worthy and well desired.
Methods:
All the target thienopyrimidine-rhodanine derivatives (5a-l) prepared from the Knoevenagel
condensation with different substituted benzaldehydes in the presence of glacial acetic acid
and 3-(thieno[2,3-d]pyrimidin-4-yl)-2-thioxothiazolidin-4-one (4). Although, all the synthesized
compounds tested for their anti-oxidant activity investigated using DPPH radical scavenging, nitric
oxide (NO) and ABTS activity.
Results:
All the thienopyrimidine-rhodanine derivatives (5a-l) were evaluated for their in vitro
anti-oxidant activity. In fact, (Z)-5-(4-methylbenzylidene)-3-(thieno[2,3-d]pyrimidin-4-yl)-2-
thioxothiazolidin-4-one (5c) with IC50 value 17.64 ± 0.06 µg/mL and (Z)-5-(2-nitrobenzylidene)-3-
(thieno[2,3-d]pyrimidin-4-yl)-2-thioxothiazolidin-4-one (5j) with IC50 value 17.54 ± 0.23µg/mL
showed excellent antioxidant activity nearly similar to the standard drug as an ascorbic acid (IC50 =
17.45 ± 0.03µg/mL).
Conclusion:
The objective of the present work was to design, synthesis and screened for their antioxidant
activities of novel thienopyrimidine containing rhodanine derivatives with the hope of discovering
new structure leads as the most potent antioxidant agents. Our aim has been achieved by
the synthesis of thienopyrimidines with diver functionalities by exploiting 2-thioxothiazolidin-4-one
chemistry and tested for antioxidant activity. The compounds 5c and 5j were found most potent
activity compare to the standard ascorbic acid. Furthermore, the electron withdrawing groups at
position-4 in benzene ring enhanced the activity, whereas the compounds 5d, 5f, 5i and 5l showed
good activity all the three radical scavenging methods.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies;Bioorganic Chemistry;2024-07
2. Synthesis, activity, docking and dynamic simulation studies of novel pyrazolo-pyrano[2,3-d]-pyrimidine analogues as anti-diabetic agents;Journal of Molecular Structure;2024-06
3. Design, Synthesis, and Molecular Docking Studies of Integrated Benzylidenethiazolidine‐2,4‐Dione and Thieno[2,3‐d]pyrimidine‐6‐Carboxylate Derivatives as Potent Antidiabetic agents;ChemistrySelect;2023-12-21
4. Synthesis, antioxidant activity and docking study of novel 3o-amine consisting 5-acetyl-6-chloroindolin-2-one analogues;Chemical Data Collections;2023-12
5. Synthesis of a novel chloroquinoline, rhodanine encompassed 1,2,3-triazole scaffolds and molecular docking evaluation of their cytotoxicity;Journal of the Iranian Chemical Society;2023-08-14